EMILY GRACE HARRIS

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NEWPORT NEWS, VA NPI 1265218317

General Payments — all program years on this page

$1,595.71

  • Category: General Payments
  • Program years: PY2024
  • Record count: 17
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,595.71 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Long term medical supply or device loan $797.608
Travel and Lodging $441.962
Food and Beverage $356.157

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2024 $1,595.7117

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1082361657 Tactile Systems Technology Inc $57.39 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082361659 Tactile Systems Technology Inc $133.27 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082361661 Tactile Systems Technology Inc $11.13 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086937367 Novartis Pharmaceuticals Corporation $5.98 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086937371 Novartis Pharmaceuticals Corporation $99.70 08/23/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086937373 Novartis Pharmaceuticals Corporation $99.70 09/27/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086937375 Novartis Pharmaceuticals Corporation $99.70 05/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086937377 Novartis Pharmaceuticals Corporation $99.70 06/13/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086937379 Novartis Pharmaceuticals Corporation $99.70 07/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086937381 Novartis Pharmaceuticals Corporation $99.70 11/14/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086937383 Novartis Pharmaceuticals Corporation $99.70 10/17/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086937385 Novartis Pharmaceuticals Corporation $99.70 12/10/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1114312428 Regeneron Healthcare Solutions, Inc. $112.49 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137117916 INTUITIVE SURGICAL, INC. $422.96 12/17/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137214551 INTUITIVE SURGICAL, INC. $19.00 12/17/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1144976658 Takeda Pharmaceuticals U.S.A., Inc. $15.65 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146729776 Ardelyx, Inc. $20.24 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.